RU2478631C2 - Соединения ((фенил)имидазолил)метилгетероарила, их применение, фармацевтическая композиция, содержащая указанные соединения, и набор, включающий такую композицию - Google Patents

Соединения ((фенил)имидазолил)метилгетероарила, их применение, фармацевтическая композиция, содержащая указанные соединения, и набор, включающий такую композицию Download PDF

Info

Publication number
RU2478631C2
RU2478631C2 RU2009145817/04A RU2009145817A RU2478631C2 RU 2478631 C2 RU2478631 C2 RU 2478631C2 RU 2009145817/04 A RU2009145817/04 A RU 2009145817/04A RU 2009145817 A RU2009145817 A RU 2009145817A RU 2478631 C2 RU2478631 C2 RU 2478631C2
Authority
RU
Russia
Prior art keywords
compounds
methyl
imidazol
phenyl
nmr
Prior art date
Application number
RU2009145817/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2009145817A (ru
Inventor
Сантош С. СИНХА
Тод М. ХЕЙДЕЛБАУ
Кен ЧОУ
Смита С. БХЭТ
Фонг Х. НГУЕН
Майкл Е. ГАРСТ
Original Assignee
Аллерган, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Аллерган, Инк. filed Critical Аллерган, Инк.
Publication of RU2009145817A publication Critical patent/RU2009145817A/ru
Application granted granted Critical
Publication of RU2478631C2 publication Critical patent/RU2478631C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RU2009145817/04A 2007-05-14 2008-05-13 Соединения ((фенил)имидазолил)метилгетероарила, их применение, фармацевтическая композиция, содержащая указанные соединения, и набор, включающий такую композицию RU2478631C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91783307P 2007-05-14 2007-05-14
US60/917,833 2007-05-14
PCT/US2008/063489 WO2008141312A1 (en) 2007-05-14 2008-05-13 ((phenyl)imidazolyl)methylheteroaryl compounds

Publications (2)

Publication Number Publication Date
RU2009145817A RU2009145817A (ru) 2011-06-20
RU2478631C2 true RU2478631C2 (ru) 2013-04-10

Family

ID=39683865

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2009145817/04A RU2478631C2 (ru) 2007-05-14 2008-05-13 Соединения ((фенил)имидазолил)метилгетероарила, их применение, фармацевтическая композиция, содержащая указанные соединения, и набор, включающий такую композицию

Country Status (16)

Country Link
US (1) US20100273814A1 (es)
EP (1) EP2155715B1 (es)
JP (1) JP5323059B2 (es)
KR (1) KR20100031502A (es)
CN (1) CN101743240B (es)
AU (1) AU2008251324B2 (es)
BR (1) BRPI0811860A2 (es)
CA (1) CA2687303C (es)
DK (1) DK2155715T3 (es)
ES (1) ES2402746T3 (es)
IL (1) IL202137A0 (es)
MX (1) MX2009012349A (es)
NZ (1) NZ599554A (es)
RU (1) RU2478631C2 (es)
WO (1) WO2008141312A1 (es)
ZA (1) ZA200908088B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2712256A1 (en) * 2008-01-18 2009-07-23 Allergan, Inc. Substitued-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors
EP3463359A4 (en) * 2016-06-02 2020-08-26 Purdue Pharma LP SPURENAMINE-ASSOCIATED RECEPTOR-1 AGONISTS AND PARTIAL AGONISTS FOR PAIN MANAGEMENT

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2232154C2 (ru) * 1999-06-10 2004-07-10 Оллерган Инк. Замещенные производные имидазола, способ введения фармацевтической композиции и способ лечения на основе этих соединений

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931714C2 (de) * 1988-09-22 1998-04-16 Minolta Camera Kk Toner zum Entwickeln elektrostatischer, latenter Bilder, umfassend spezifizierte Imidazole
US5750720A (en) * 1996-03-28 1998-05-12 Ortho Pharmaceutical Corporation 4- (thien-3-yl)methyl!-imidazole analgesics
US6841684B2 (en) * 1997-12-04 2005-01-11 Allergan, Inc. Imidiazoles having reduced side effects
JP2008514603A (ja) * 2004-09-24 2008-05-08 アラーガン、インコーポレイテッド α２アドレナリン作動剤としての４−（ヘテロアリール−メチルおよび置換ヘテロアリール−メチル）−イミダゾール−２−チオン

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2232154C2 (ru) * 1999-06-10 2004-07-10 Оллерган Инк. Замещенные производные имидазола, способ введения фармацевтической композиции и способ лечения на основе этих соединений

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Boyd R.E. et al: "α 2 -Adrenoceptor agonists as potential analgesic agents. 1. (Imidazolylmethel)oxazoles and -thiazoles", Journal of Medicinal Chemistry, vol.42, 1999, pp.5064-5071. *
ZHANG X. et al: "Medetomidine analogs as alpha 2-adrenergic ligands. 2. Design, synthesis and biological naphthalene derivatives of medetomidine", JOURNAL OF MEDICINAL CHEMISTRY, vol.39, 1996, pp.3001-3013. *

Also Published As

Publication number Publication date
ZA200908088B (en) 2010-12-29
EP2155715A1 (en) 2010-02-24
NZ599554A (en) 2013-12-20
JP2010527369A (ja) 2010-08-12
CN101743240B (zh) 2013-07-17
CA2687303A1 (en) 2008-11-20
CN101743240A (zh) 2010-06-16
EP2155715B1 (en) 2013-03-13
RU2009145817A (ru) 2011-06-20
CA2687303C (en) 2015-05-05
ES2402746T3 (es) 2013-05-08
WO2008141312A1 (en) 2008-11-20
AU2008251324B2 (en) 2014-05-01
MX2009012349A (es) 2009-12-01
AU2008251324A1 (en) 2008-11-20
KR20100031502A (ko) 2010-03-22
IL202137A0 (en) 2010-06-16
DK2155715T3 (da) 2013-05-13
JP5323059B2 (ja) 2013-10-23
BRPI0811860A2 (pt) 2014-11-18
US20100273814A1 (en) 2010-10-28

Similar Documents

Publication Publication Date Title
US7399868B2 (en) 4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
US20220162203A1 (en) Heteroaryl derivative, method for producing same, and pharmaceutical composition comprising same as effective component
NO302522B1 (no) 4-pyrimidinyl- og pyridinylderivater av indolyl-3-yl-alkylpiperazin og farmasöytisk preparat som inneholder en slik forbindelse
RU2383535C2 (ru) 4-(фенилметил и замещенный-фенилметил)-имидазол-2-тионы, действующие как специфические альфа2-адренергические агонисты
CA2781858C (en) Modulators of tnf-.alpha. signaling
KR20100046064A (ko) 인다졸 아크릴산 아미드 화합물
RU2478631C2 (ru) Соединения ((фенил)имидазолил)метилгетероарила, их применение, фармацевтическая композиция, содержащая указанные соединения, и набор, включающий такую композицию
MXPA04005810A (es) Derivados de 3 (fenilalcoxi) -5- (fenil)piridina y compuestos relacionados como inhibidores de quinasa para el tratamiento de cancer.
RU2472788C2 (ru) ((бициклогетероарил)имидазолил)метилгетероарильные соединения как агонисты адренергических рецепторов
EP2393800B1 (en) Pyridine compounds as subtype selective modulators of alpha2b and/or alpha 2c adrenergic receptors
EP3130589A1 (en) Heterocyclic aza compounds
US20240150337A1 (en) Heteroaryl derivative, method for producing same, and pharmaceutical composition comprising same as effective component
KR20100071990A (ko) 녹내장 및 통증과 같은 질환의 처치에 유용한 헤테로사이클 치환된 융합 카르보사이클
US8383646B2 (en) Therapeutic ((bicylicheteroaryl)imidazolyl) methylheteroaryl compounds
AU2008256928A1 (en) Therapeutic ((phenyl)imidazolyl)methylquinolinyl compounds

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20170514